Atlas Trials

Graves Orbitopathy

14 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Graves Orbitopathy

RecordFirmDate
A Phase 2b, Study of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED) (NCT05276063)Sling Therapeutics, Inc.2022-07-01
A Study of the Efficacy and Safety of Secukinumab 300 mg in Patients With Thyroid Eye Disease (TED) (NCT04737330)Novartis Pharmaceuticals2021-11-29
Antithymocyte Globulin as a Second Line Therapy in Graves Orbitopathy (NCT05199103)Medical University of Silesia2020-01-01
Treatment of Graves' Orbitopathy (Thyroid Eye Disease) to Reduce Proptosis With Teprotumumab Infusions in a Randomized, Placebo-Controlled, Clinical Study (NCT03298867)Amgen2017-10-04
Expanded Access Protocol of Teprotumumab (HZN-001) for Patients With Active Thyroid Eye Disease (NCT04040894)Amgen

Track Graves Orbitopathy automatically

Every clearance here is in the API, with alerts when new ones post.